Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
March 3, 2026
Photobiomodulation (PBM) Therapy for Prevention of Oropharyngeal Mucositis in Pediatric Hematopoietic Stem Cell Transplant Patients
RL
Rachel M Lott
RW
Randy M. Windreich
Puntos clave
Oropharyngeal mucositis incidence decreased, and PBM therapy showed promise in reducing discomfort.
The reduction in mucositis rates was significant, with some patients experiencing less severe symptoms.
Analysis utilized a prospective observational design, focusing on pediatric patients undergoing stem cell transplants.
Highlights the potential for PBM as an effective intervention for preventing treatment-related complications in children.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Lott et al. (Sun,) studied this question.
synapsesocial.com/papers/69a76084c6e9836116a2d56e
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.702
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Photobiomodulation (PBM) Therapy for Prevention of Oropharyngeal Mucositis in Pediatric Hematopoietic Stem Cell Transplant Patients | Synapse